Inosine 5′-Triphosphate (Sodium Salt)

Description

Inosine 5′-Triphosphate (Sodium Salt)
Catalog number: B2013106
Lot number: Batch Dependent
Expiration Date: Batch dependent
Amount: 10 mg
Molecular Weight or Concentration: 574.1 g/mol
Supplied as: Lyophilized Powder
Applications: molecular tool for various biochemical applications
Storage: -20°C
Keywords: inosine 5′-(tetrahydrogen triphosphate), trisodium salt
Grade: Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um.

References:
1: Senthilvelan A, Shanmugasundaram M, Kore AR. An efficient protection-free chemical synthesis of inosine 5′-nucleotides Nucleosides Nucleotides Nucleic Acids. 2020;39(6):829-837.
2: Morgan MA, Shatkin AJ. Initiation of reovirus transcription by inosine 5′-triphosphate and properties of 7-methylinosine-capped, inosine-substituted messenger ribonucleic acids Biochemistry. 1980 Dec 23;19(26):5960-6.
3: Nakahara K, Hataya T, Uyeda I. Inosine 5′-triphosphate can dramatically increase the yield of NASBA products targeting GC-rich and intramolecular base-paired viroid RNA Nucleic Acids Res. 1998 Apr 1;26(7):1854-6.
4: Loukovaara S, Sahanne S, Jalkanen S, Yegutkin GG. Increased intravitreal adenosine 5′-triphosphate, adenosine 5′-diphosphate and adenosine 5′-monophosphate levels in patients with proliferative diabetic retinopathy Acta Ophthalmol. 2015 Feb;93(1):67-73.
5: Nyström K, Wanrooij PH, Waldenström J, Adamek L, Brunet S, Said J, Nilsson S, Wind-Rotolo M, Hellstrand K, Norder H, Tang KW, Lagging M. Inosine Triphosphate Pyrophosphatase Dephosphorylates Ribavirin Triphosphate and Reduced Enzymatic Activity Potentiates Mutagenesis in Hepatitis C Virus J Virol. 2018 Sep 12;92(19):e01087-18.
6: Hourani SM, Bailey SJ, Johnson CR, Tennant JP. Effects of adenosine 5′-triphosphate, uridine 5′-triphosphate, adenosine 5′-tetraphosphate and diadenosine polyphosphates in guinea-pig taenia caeci and rat colon muscularis mucosae Naunyn Schmiedebergs Arch Pharmacol. 1998 Oct;358(4):464-73.
7: Carson DA, Wasson DB. Characterization of an adenosine 5′-triphosphate- and deoxyadenosine 5′-triphosphate-activated nucleotidase from human malignant lymphocytes Cancer Res. 1982 Nov;42(11):4321-4.
8: Göttle M, Dove S, Seifert R. Bacillus anthracis edema factor substrate specificity: evidence for new modes of action Toxins (Basel). 2012 Jul;4(7):505-35.
9: Sigel H, Bianchi EM, Corfù NA, Kinjo Y, Tribolet R, Martin RB. Stabilities and isomeric equilibria in solutions of monomeric metal-ion complexes of guanosine 5′-triphosphate (GTP4-) and inosine 5′-triphosphate (ITP4-) in comparison with those of adenosine 5′-triphosphate (ATP4-) Chemistry. 2001 Sep 3;7(17):3729-37.
10: Hübner M, Dixit A, Mou TC, Lushington GH, Pinto C, Gille A, Geduhn J, König B, Sprang SR, Seifert R. Structural basis for the high-affinity inhibition of mammalian membranous adenylyl cyclase by 2′,3′-o-(N-methylanthraniloyl)-inosine 5′-triphosphate Mol Pharmacol. 2011 Jul;80(1):87-96.

Products Related to Inosine 5′-Triphosphate (Sodium Salt) can be found at Chemicals